Fiskio et al., "An evaluation of risk factors for adverse drug events associated with angiotensin-converting
enzyme inhibitors," Journal of Evaluation in Clinical Practice, vol.
Zivljenje ogrozajoc angioedem po zaviralcu angiotenzinove konvertaze: prikaz dveh primerov [Life-threatening angioedema induced by angiotensin-converting
enzyme inhibitor: two case reports].
The development of angiotensin I-converting
enzyme inhibitor derived from chicken bone protein.
The aim of this study was to elucidate the combined effect of the clinically used vitamin K(2) (VK) and angiotensin-converting
enzyme inhibitor (ACE-I) on cumulative recurrence after curative treatment on a total of 87 patients, especially in consideration of neovascularization.METHODS: VK (menatetrenone; 45 mg/day) and/or ACE-I (perindopril; 4 mg/day) were administered for 36-48 months after curative therapy for HCC.
A potential immunotherapy, a new gene therapy, an
enzyme inhibitor, and a compound originally isolated from a Chinese herb are among the latest approaches scientists are proposing to treat addiction.
Lead researcher Dr Gerd Wagner, from the University of East Anglia, said: "This exciting discovery of a potent
enzyme inhibitor with a completely new mechanism of action has considerable therapeutic potential in cancer, inflammation and infection.
The actual ingredients are an angiotensin-converting
enzyme inhibitor (ramipril 5 mg), a beta-blocker (atenolol 50 mg), a diuretic (hydrochlorothiazide 12.5 mg), the statin simvastatin 20 mg, and aspirin 100 mg.
Angiotensin-converting
enzyme inhibitor induced syndrome of inappropriate secretion of antidiuretic hormone: case report and review of the literature.
Hsu, Bates, Kuperman & Curhan (2001), in their study, "Blood pressure and angiotensin converting
enzyme inhibitor use in hypertensive patients with chronic renal insufficiency," sought to investigate actual clinical management of hypertension in 3,089 ambulatory patients with CKD by using medical record information from a Massachusetts hospital.
Coreg is an excellent drug for this problem, and often an angiotensin-converting
enzyme inhibitor or receptor blocker is added.
Shades of colour can be correlated to the amount of substrate or
enzyme inhibitor present.
The covalently bound entity may also serve as an antagonist or agonist of a particular binding protein or as an
enzyme inhibitor. (US 7,166,695)